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Abstract
Introduction. Acute kidney injury (AKI) is a common clinical problem associated with adverse out-
comes. This study identiﬁes the incidence of AKI in two UK district general hospitals’ without
on-site renal services and assesses AKI management and level of nephrologist input.
Methods. The AKIN classiﬁcation was used to identify 1020 AKI patients over 6 months. Data were
collated on patient demographics, AKI management and referral to nephrology and intensive care
services. Short/long-term renal outcomes were investigated. Patients were followed up for 14
months post-discharge.
Results. Incidence of hospital-based AKI was 6.4%. Mean patient age was 73 years. There was
28.1% acute in-hospital mortality with a further 21.6% 14-month mortality. Only 8.3% of patients
were referred to nephrology services for in-hospital review, and only 8.1% had outpatient nephrol-
ogy follow-up. Compliance with the AKI National Conﬁdential Enquiry into Patient Outcomes and
Deaths (NCEPOD) recommendations was poor with 32.8% of patients having renal imaging and
15% of patients having acid–base status assessed. NCEPOD compliance improved with nephrology
input. Patients referred to nephrology were likely to be younger with pre-existing CKD and severe
AKI. 10.5% of AKI episodes were unrecognized. Forty percent of those with unrecognized AKI,
(compared with 15% of recognized AKI) developed de novo or progression of pre-existing CKD.
Conclusion. AKI in DGHs is mostly managed without nephrology input. There are signiﬁcant short-
comings in AKI recognition and management in this setting. This is associated with poor mortality
and long-term CKD. This study supports a need to improve the teaching and training of front-line
medical staff in identifying AKI. Additionally, implementation of AKI e-alert systems may encou-
rage early recognition and provide a prompt for renal referral.
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Introduction
Acute kidney injury (AKI) is common in hospitalized
patients and is associated with serious long-term adverse
implications on patient outcome [1–4]. Clinically, AKI can
easily be recognized through monitoring of urine output
and analysis of simple serum biochemistry. In the UK,
however, the AKI National Conﬁdential Enquiry into
Patient Outcomes and Deaths (NCEPOD) report published
in 2009 reported major deﬁciencies in recognition and
clinical care of patients with AKI [5]. In spite of this report
and despite signiﬁcant advances in health care, recent
studies have, if anything, demonstrated an increasing inci-
dence of AKI [2, 6–10]. At present, the reason for the rise
of AKI in hospitalized patients and the inﬂuence of the
publication of the AKI NCEPOD report in the management
of AKI patients is not apparent. It is also not entirely clear
whether involvement of specialist nephrology services im-
proves outcomes in AKI. In this study, we identify and
characterize a cohort of patients with AKI in two district
general hospitals in the UK over a 6-month period. We
study AKI management in these patients according to a
number of NCEPOD criteria and investigate the level of
nephrology input into management of patients with AKI.
Methods
The study was conducted over 6 months in two large dis-
trict general hospitals (DGHs) in the UK. These hospitals
have no on-site nephrology unit. Data were collected from
electronic records of all adult medical and surgical
patients admitted to the two DGHs that form the Aneurin
Bevan Health Board in South-East Wales. These are Neville
Hall Hospital (500 beds, 8 Critical Care beds) and Royal
Gwent Hospital (774 beds, 16 Critical Care beds). Com-
bined they serve an estimated population of 639 000.
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These hospitals also do not provide cardiothoracic
surgery, neurosurgery, plastics or transplantation surgery.
Two nephrologists reviewed electronic biochemistry
records of all medical and surgical admissions to these
hospitals. All patients admitted between 11 July 2011 up
to and including 15 January 2012 were included, unless
already on maintenance renal replacement therapy. Ad-
missions through general practice, accident and emer-
gency and hospital outpatient clinics were included. AKI
was deﬁned according to the AKI Network classiﬁcation,
and creatinine criteria were used for identiﬁcation of AKI
[11]. Baseline serum creatinine (sCr) values for patients
admitted with evidence of AKI on their serum biochemis-
try were determined through review of all sCr values taken
from the patient over the preceding 12-month period. (All
GP practices and peripheral hospitals within the Aneurin
Bevan trust utilize a central laboratory for biochemical
processing and hence all community and hospital blood
tests were available for scrutiny in this assessment.) Base-
line sCr for patients who developed AKI during their hospi-
tal stay was taken as sCr on admission, and conﬁrmed to
be representative of true baseline by review of 12 months
prior results. Where no baseline sCr was available (49
patients), the percentage increase that deﬁnes AKI was
calculated using the upper limit of normal laboratory re-
ference range for sCr in males and females, respectively.
In addition, for patients with unknown baseline values, we
were able to chart the sCr after resolution of AKI, which
further enabled approximation of baseline sCr and conﬁr-
mation of true AKI. This method of identiﬁcation of base-
line sCr levels has been recommended in the recently
published Kidney Disease Improving Global Outcomes
(KDIGO) AKI guidelines [12].
Data were collated on age, sex, admission method, admit-
ting specialty, length of hospital stay, intensive care unit
(ITU) admission and length of ITU stay, in-hospital renal re-
covery and in-hospital mortality. Data were also collected on
referral to renal services, days to renal review and/or transfer
to renal unit. Recovery from an AKI episode was deﬁned as
achievement of a creatinine no longer in keeping with AKI
deﬁnition (according to AKIN criteria). Patients were deﬁned
as having missed/unrecognized AKI if they were discharged
from hospital with worsening renal function and with no AKI
acknowledged in their hospital discharge letter.
Long-term mortality outcomes were assessed over 14
months from date of discharge. Development of de novo
CKD and progression of pre-existing CKD was deﬁned as an
eGFR decline of >15% or fall in eGFR of >5 mL/min/year ac-
cording to UK CKD guidelines and NICE CKD guidelines [13,
14]. CKD was identiﬁed either from electronic clinical letters,
and/or from blood tests indicating that their baseline eGFRs
were <60 mL/min according to the NICE CKD guidelines [14].
Statistical analysis was carried out using SPSS 20. Student’s
t-test, Pearson’s χ2 test and one-way ANOVA were used for
analysis of normally distributed data. Otherwise, Mann–
Whitney U-test, Wilcoxon signed-rank test and Kruskal–Wallis
test were used. Continuous variables were described using
mean and SD or median with interquartile range (IQR).
P-values of <0.05 were deemed statistically signiﬁcant.
Results
Patient characteristics
During the stated 6 months, there were 15 976 admissions
to the two DGHs. Of these, 1020 patients with AKI were
identiﬁed according to the AKIN criteria, giving an overall
AKI incidence of 6.4%. The incidence of AKI admitted
under medical specialties was 7% and under surgical spe-
cialties was 4.2%. Median number of in-patient days for
the AKI admissions was 9 days (IQR 16 days, range 0–177
days). Six hundred and eighty-six (67.25%) patients devel-
oped AKI in the community and were admitted to hospital
with AKI. The remaining 334 (32.75%) acquired AKI during
hospitalization. The incidence of AKI was equal in males
and females with 515 (50.5%) episodes in men and 505
(49.5%) episodes in women. Three hundred and twenty-
three (31.7%) had acute on chronic kidney injury. These
data are outlined in Table 1.
AKI characteristics and outcomes
A total of 45.5% patients had Stage 1 AKI, 30% had Stage
2 AKI and 25% had AKI Stage 3. 46.7% of AKI episodes re-
covered to baseline sCr. A total of 13.6% developed either
de novo CKD or progression of pre-existing CKD, while
0.9% were discharged from hospital requiring RRT. Of the
patients with AKI, 28.1% died within their hospital admis-
sion and 10.5% of AKI episodes were identiﬁed as unrec-
ognized (Table 1). Post-discharge, a further 21.6% of
patients died within 14 months of their AKI episode,
giving an overall 14-month mortality of 49.7% (n = 507).
Involvement of nephrology services in AKI management
Only 85 (8.3%) patients were referred to nephrologists. Of
these, 12 (14%) were Stage 1 AKI, 15 (18%) were Stage 2
AKI and 58 (68%) were AKI Stage 3. Only 22.8% of Stage 3
AKI and 5% of Stage 2 were referred to nephrology
(Figure 1A). Patients referred to nephrology services were
statistically more likely to be younger, with pre-existing
CKD and more severe AKI in association with a higher
mean peak creatinine and potassium. Those referred were
Table 1. Patient demographics, AKI characteristics and in-hospital
outcomes
Sex, n (%) Pre-existing CKD
Male 515 (50.5) Total, n (%) 323 (31.7)
Female 505 (49.5)
Age (mean ± SD)
CKD 1 and 2 17 (5.3)
All AKI 73 ± 16.4 CKD 3a 62 (19.2)
Male 74.2 ± 14.3 CKD 3b 145 (44.9)
Female 76.3 ± 15.0 CKD 4 92 (28.5)
CKD 5 7 (2.2)
Hospital, n (%) Admissions method, n (%)
RGH 521 (51.1) GP 614 (60.2)
NHH 499 (48.9) A&E 363 (35.6)
Transfer/booked 27 (2.6)
Via clinic 16 (1.6)
Specialty, n (%) AKI stage, n (%)
Medical 876 (85.9) Stage 1 464 (45.5)
Surgical 144 (14.1) Stage 2 304 (29.8)
Stage 3 252 (24.7)
In-hospital outcomes, n(%)
Recovery 476 (46.7) RRT 9 (0.9)
CKD progression 59 (5.8) Death 287 (28.1)
New CKD label 80 (7.8) Unrecognized AKI 107 (10.5)
Unknown 2 (0.2)
CKD, chronic kidney diseas; GP, general practice; A&E, accident and
emergency; RRT, renal replacement therapy.
Demonstrates the demographics, characteristics and in-hospital outcomes
of all patients identiﬁed as having AKI between 11 July 2011 and 15
January 2012.
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also more likely to require ITU and had longer hospital
stays (Table 2).
Referral outcomes
A third of patients referred to nephrologists were referred
via telephone to the registrar at the tertiary renal unit,
while a third were referred for in-patient review by the
outreach Nephrology Consultant. Sixteen percent were
referred through both methods and a further 16.5% only
referred for outpatient renal review (Figure 1B). Outcomes
of nephrology referrals are demonstrated in Figure 1C. A
total of 25.9% of referrals were listed for transfer to the
renal unit. A total of 21.2% were put on the renal unit’s
‘Watch List’. This list comprises a group of patients who
are not listed for transfer but are monitored by nephrolo-
gists remotely and telephone advice is given to medical
teams under which the patient is admitted. These
patients may be listed for transfer if their renal par-
ameters worsen. A total of 16.5% were listed for outpati-
ent review following in-patient review, and 4.7% were
deemed palliative and suitable for conservative care. A
total of 18.8% were listed for outpatient review following
discharge.
Acute RRT
Twenty-ﬁve patients required RRT for AKI. Fourteen
percent (n = 12) of these had haemoﬁltration, while 12%
(n = 10) had haemodialysis. 3.5% (n = 3) had both haemo-
ﬁltration and haemodialysis. Overall, 65 patients (6.4%)
were referred to ITU for management, of these 17
patients were admitted for only renal support while await-
ing transfer to the renal unit.
Referral waiting times
The mean number of days between date of AKI onset and
referral to nephrology was 3.5 ± 6.4 days. The mean
number of days between referral and in-patient nephrol-
ogy review was 2.9 ± 3.9 days. Waiting times for transfer
to the renal unit was 2.2 ± 3.7 days. Minimum wait for
transfer was 0 days and maximum wait was 14 days.
A proportion of patients were transferred to ITU for renal
support prior to transfer to the renal unit. For these, the
mean wait on ITU prior to transfer was 1.4 ± 1.7 days. The
minimum wait on ITU was 0 days and maximum wait
5 days.
Fig. 1. (A) Demonstrates the percentages of patients in Stages 1, 2 and 3 AKI referred to nephrology services. Referral includes telephone discussion with
renal team regarding the patient, in-patient review or transfer to renal unit. Patients sustaining AKI Stage 3 were signiﬁcantly most likely to be referred
(Pearson’s χ2 test, P < 0.001). (B) Demonstrates percentages of patients referred to nephrology services categorized according to method of referral. OP,
outpatient. (C) Demonstrates the outcome once patients have been referred to nephrology. Percentage of patients in each category is denoted with each
individual bar. Patients ‘listed for OP only’ were not reviewed by a renal physician during their in-patient stay.
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Post-discharge follow-up
Only 8.1% of AKI patients were reviewed by nephrologists
post-discharge. The majority of these were those that had
been referred to nephrology services while an in-patient.
A total of 34.2% had no follow-up planned, while 22.3%
were followed-up by their GP or another hospital specialty.
62.5% were discharged from hospital with an eGFR of <60
mL/min/1.73 m2. However, only 13.3% of these patients
were referred for outpatient nephrology review.
NCEPOD compliance
Among the recommendations outlined in the AKI NCEPOD
report are appropriate assessment of acid–base status
and renal imaging [5]. Only 32.8% of AKI’s in this study
had renal imaging performed, with only half of all AKI
Stage 3 undergoing renal imaging (Figure 2A). Of those
imaged (70 patients), 20.9% had some degree of obstruc-
tive pathology identiﬁed. Only 15% of AKI patients had
acid–base status assessment performed (median serum
bicarbonate 18 mmol/L, IQR 15–22), with only a third of
AKI Stage 3 having this checked. Referral to nephrology
was associated with marked improvement in NCEPOD
compliance (Figure 2B). Only 40% of AKI hospital dis-
charges had AKI mentioned in discharge documentation
to primary care (Figure 2C).
Unrecognized AKI
One hundred and seven patients (10.5%) with AKI were
discharged from hospital with missed/unrecognized AKI.
Fifty-two percent (n = 56) of these patients were re-hospi-
talized within 6 months, with a total of 93 re-
hospitalization events. 23.3% (n = 25) had pre-existing
CKD and 75% (n = 80) had AKI apparent on admission
bloods. 21.5% (n = 23) were AKI Stage 2 and 6.5% (n = 7)
were AKI Stage 3. One patient with missed AKI had a
serum potassium level >6 mM and three patients had hae-
molysed serum potassium samples, which were not re-
peated. Table 3 compares data in patients with recognized
versus unrecognized AKI. Patients with unrecognized AKI
were more likely to be admitted under surgical specialties,
were less likely to have pre-existing CKD and were more
likely to have less severe AKI. Moreover, they had shorter
hospital admissions. A total of 32.7% of patients with un-
recognized AKI died within 14 months of admission. Of
patients with recognized AKI, 16.5% developed CKD by 14
months. In comparison, 42% of patients with unrecog-
nized AKI developed CKD by 14 months.
AKI analyses by hospital
The incidence of AKI was greater in RGH than NHH (7.8
versus 5.6%, P < 0.001), with a greater proportion of HA-
AKI which is reﬂective of RGH being the larger of the DGHs.
However, there were no signiﬁcant differences in AKI se-
verity, NCEPOD compliance (as detailed above) or in-
patient outcomes of AKI categorized as per Table 1.
Speciﬁcally, there were equal proportions of missed AKI in
both hospitals (10.7 and 10.2%, respectively). Renal refer-
ral rates were also equivalent (8.3 and 8.4%). There were
no signiﬁcant differences between hospitals in the long-
term (14 months) renal outcomes deﬁned as de novo CKD
or progression of existing CKD (data not shown).
Discussion
AKI is a common clinical problem faced by a variety of
specialists including general physicians, surgeons, intensi-
vists and nephrologists. Several studies have demonstrated
that AKI is associated with adverse patient outcomes
including prolonged hospital stay, increased mortality and
a heightened risk of developing CKD [3, 15–19]. Many of
these risks persist well after hospital discharge, demon-
strating high personal and health-care costs. AKI risk is
heightened in the elderly and in individuals with increased
comorbid illnesses [8]. With an ageing population and a
rising burden of chronic disease, AKI and ensuing CKD will
continue to represent a signiﬁcant problem faced by many
specialties. It is becoming increasingly vital to implement
health strategies within hospital front-line and specialist
services that are aimed at prevention and optimum man-
agement of this condition. This large study based in two
DGHs in the UK identiﬁed an AKI incidence of 6.4%, of
which approximately a third of patients had underlying
CKD. Only 8.3% of AKI patients and 22.8% of patients with
severe AKI were referred to nephrology. Thus, in the setting
of a DGH with no dedicated in-patient nephrology service,
AKI is almost entirely managed by general physicians and
surgeons.
The National Service Framework for Renal Services in
the UK published in 2010 recommends that patients at
risk of or with AKI should be promptly identiﬁed and given
high-quality, clinically appropriate care in partnership with
specialist renal teams [20]. Recently, KDIGO have pub-
lished guidelines recommending that a nephrologist
should follow-up survivors of AKI within 90 days of the AKI
event [12]. In 2009, a national UK audit was performed
Table 2. Patient demographic data comparing referred and non-referred
AKI
Referred to renal
(n = 85)
Nonreferred
(n = 935)
P
value
Age (mean ± SD) 68.5 ± 17.3 75.8 ± 14.3 <0.001
Male, % (n) 55.3 (47) 50.1 (468) 0.36
Pre-existing CKD, % (n) 57.6 (49) 29.3 (274) <0.001
AKI at point of
admission, % (n)
83.5 (71) 65.8 (615) 0.001
AKI Severity, % (n)
Stage 1 14.1 (12) 48.3 (452) 0.001
Stage 2 17.6 (15) 30.7 (287) 0.013
Stage 3 68.2 (58) 21 (196) 0.001
Length of in-patient
stay (mean days ± SD)
19.5 ± 18.2 15 ± 19.2 0.03
ITU admission, % (n) 21.2 (18) 5.0 (47) <0.001
Biochemistry and radiology
Imaging performed,
% (n)
82.4 (70) 29.1 (272) <0.001
Acid–base status
check, % (n)
58.5 (50) 11 (103) <0.001
Peak creatinine
(mean ± SD)
534.6 ± 301.2 235.4 ± 131.4 <0.001
Potassium at peak Cr
(mean ± SD)
5.1 ± 1.1 4.6 ± 0.9 <0.001
The table demonstrates patient demographics and AKI characteristics for
all the identiﬁed AKIs between June 2011 and January 2012, categorized
according to whether patients were referred to nephrology services or not.
Comparison is also made between admission to ITU and compliance with
NCEPOD recommendations between these two groups. P-value for non-
normally distributed continuous variables (age, length of stay, peak Cr) are
calculated using Mann–Whitney U-test. Normal data (peak potassium) are
compared using Student’s t-test. P values reported for categorical
variables using Pearson’s χ2 test/Fisher’s exact test where appropriate. A
P-value of <0.05 was deemed as statistically signiﬁcant.
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evaluating recognition and management of AKI in
patients who subsequently died [5]. This audit identiﬁed
deﬁciencies in AKI management in ∼50% of cases. In this
study, only a third of AKI patients had renal imaging per-
formed during their admission and only half of the
patients with severe AKI had renal imaging performed.
Furthermore, in 20.9% of those imaged, urological pathol-
ogy was identiﬁed. While it is beyond the scope of this
study to evaluate management of individual AKI cases,
this highlights the potential for missing reversible AKI
causes amenable to radiologic intervention in two thirds
of this patient cohort. Assessment of acid–base status
was also poor, with only a third of severe AKI and 15% of
AKI patients overall having this performed. Furthermore,
only 8.1% patients were seen by nephrology post-dis-
charge, despite a large proportion developing CKD.
Patients who did have planned outpatient review were
those that had been referred to nephrology during their
admission, with a signiﬁcant proportion of the remaining
patients not having the episode of AKI documented as
part of their hospital discharge letter to alert the commu-
nity team to the patients heightened risk of CKD and
death. Thus, according to Renal NSF and KDIGO rec-
ommendations, this study identiﬁes signiﬁcant shortcom-
ings in AKI management. Furthermore, despite publication
of the AKI NCEPOD audit 2 years prior to this study, little
improvement has been made in basic management of
patients with AKI.
According to the AKI NCEPOD enquiry, lack of specialist
input was one of the factors that led to poor care delivery
[5]. This was also a likely important factor in this study as
NCEPOD compliance improved in patients that were
referred to renal services. It also suggests that the
NCEPOD enquiry has had little impact on care outside
nephrology. Patients were more likely to be referred to
nephrology if they had severe AKI, AKI on admission, pre-
existing CKD or if they were transferred to ITU, indicating
that, in these circumstances, doctors were more easily
able to recognize importance of nephrology input. It was
also clear that age plays a role in the decision for referral.
It may have been appropriate to not refer some elderly
patients if their care was palliative. However, as patients
are surviving longer with multiple comorbid conditions,
the importance of developing an optimum management
approach in elderly patients with AKI becomes increas-
ingly crucial. In the UK, the number of elderly patients on
RRT programmes is increasing; thus, it may be considered
as ageist to not offer the elderly the beneﬁt of health care
that may enhance recovery from AKI, limit progression to
CKD and reduce mortality. Conversely, if nephrologists
were to see all AKI inpatients and organize subsequent
90-day outpatient review for these patients, this would
overwhelm nephrology services and impact on care deliv-
ery across other aspects of nephrology. Careful consider-
ation needs to be given to a measured and appropriate
reconﬁguration of nephrology services to assist in optimal
AKI management. Additionally, development of nephrol-
ogy-led education and training programmes for front-line
and general hospital teams, with the implementation of
AKI care pathways as advised by KDIGOmay be effective.
As kidney disease is generally silent, it can often go un-
noticed without meticulous attention to blood results and
urine output. In contrast to the CKD staging system, the
AKI staging system has received little attention in clinical
practice and appears to play only a small role in AKI recog-
nition. This study identiﬁes a concerning trend of patients
discharged with unrecognized AKI. The need for clinicians
to be vigilant of AKI is important for several reasons; it
may be predictive of a longer in-hospital stay, it identiﬁes
the patient’s heightened short and long-term mortality
risk, and it identiﬁes the increased risk of developing CKD.
Patients with unrecognized AKI were more likely to be ad-
mitted under surgical specialties, speciﬁcally highlighting
the need to focus AKI education/training in this discipline.
Unrecognized AKI did not appear to impact on long-term
mortality. However, it did impact signiﬁcantly on CKD
development, with over 40% of patients with unrecog-
nized AKI developing either de novo CKD or as progression
of pre-existing CKD. There is unequivocal evidence that
CKD progression can be slowed by optimal management
of hypertension and proteinuria [21]. Thus, this work illus-
trates the need for improving AKI awareness, and has
prompted us to set-up an AKI alert system in both of
these hospitals to improve recognition.
Our study has a number of limitations. There was no
information on aetiology of AKI or on the cause of death
in our patient cohort. Patients on palliative care pathways
were not excluded, although by deﬁnition they may not
have been being biochemically monitored, and therefore
should not impact signiﬁcantly on our ﬁndings. In addition,
as information was gathered retrospectively from an elec-
tronic database, information on differences in patient man-
agement could not be reliably obtained. Furthermore,
although overall patient numbers were large, the cohort of
patients referred to nephrology was small in comparison to
the non-referred group, thus introducing difﬁculty in con-
cluding any difference in outcomes, and hence not pre-
sented in this work. Further research should focus on
elucidating speciﬁc differences in AKI care in those referred
Table 3. Unrecognized AKI
Missed AKI
(n = 107)
All other
outcomes
(n = 913) P value
Age (mean ± SD) 76 ± 15.0 75.1 ± 14.7 0.479a
Male, % (n) 48.6 (52) 50.7 (463) 0.679
Hospital
RGH, % (n) 52.3 (56) 50.9 (465) 0.783
NHH, % (n) 47.7 (51) 49.1 (448)
Admission route, % (n)
GP 58.9 (63) 60.4 (551) 0.403
A&E 35.5 (38) 35.6 (325)
Transfer/other 1.9 (2) 2.5 (23)
Clinic 3.7 (4) 1.3 (12)
Specialty admitted under
Medicine, % (n) 78.5 (84) 86.7 (792) 0.027
Surgery, % (n) 21.5 (23) 13.3 (121)
Pre-existing CKD, % (n) 23.4 (25) 32.6 (298) 0.034
AKI at point of admission,
% (n)
74.8 (80) 66.4 (606) 0.061
AKI severity, % (n)
Stage 1 72 (77) 42.4 (387) <0.001
Stage 2 21.5 (23) 30.6 (279) 0.033
Stage 3 6.5 (7) 27.1 (247) <0.001
Length of IP stay (mean
days ± SD)
6.5 ± 12.3 16.4 ± 19.5 <0.001a
Long-term outcomes, % (n)
Died 32.7 (35) 52.2 (471) 0.0002b
De novo CKD or
progression of pre-
existing CKD
39.3 (42) 16.5 (149) <0.0001b
No CKD 28 (30) 31.3 (283) 0.51b
Demographics, characteristics and outcomes of recognized versus missed
AKI.
aP values calculated using Mann–Whitney U-test.
bP values calculated using Fisher’s exact test. All other P values calculated
using Pearson’s χ2 test. P < 0.05 deemed as statistically signiﬁcant.
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to renal services compared with those managed solely by
DGH medics in order to fully understand any deﬁciencies in
AKI management that might be improved by bettering
education. Finally, these results, although maybe represen-
tative of other DGHs within the UK, are unlikely to be appli-
cable to teaching hospitals with on-site specialist renal
units.
In conclusion, this study shows that AKI in DGHs is
managed by medical and surgical specialties with limited
nephrology input. It highlights serious shortcomings in
AKI recognition and management and highlights an
urgent need for clear guidance for colleagues in all disci-
plines on recognition and management of AKI and appro-
priate referral to nephrology services. Implementation of
AKI-eAlert systems may assist in this important reform.
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